Program

8:00 am to 5:00 pm

Nursing Research and Practice: Innovation, Impact, and All That Jazz

(Click title for additional details).

Speakers

Barbara Riegel, DNSC, RN, DAAN, FAHA
Corrine Jurgens, RN, PhD
K. M. Reeder, RN, PhD
Nancy Redeker, PhD, RN, FAHA, FAAN
Peggy Kalowes, PhD, RN, CNS, FAHA
Susan J. Pressler, PhD, RN, FAAN, FAHA

The Pharmacology of Drugs for Common Co-Morbidities: Will They Impact HF Treatment?

(Click title for additional details).

Speakers

Amy Kennedy, PhD
Anecita Fadol, PhD, RN, FNP, FAANP
Peggy Kirkwood, RN, MSN, ACNPC, AACC, CHFN
Robert Lee Page II, MSPH, FCCP, FASHP, FASCP, FAHA, BCPS, CGP
Rose Quiroga, RN, BSN
Sabrina White, DNP, APRN, ACNP-BC
Steven Thai, PhD
Joseph Ho, PharmD

Thinking Outside the Box: Creative Strategies for Heart Failure Disease Management Pre-Conference Workshop

(Click title for additional details).

Speakers

Cheri Basso BSN, RN-BC, CHFN
Julie Gee, MSN, CNP, CHFN
Lisa Rathman, MSN, CRNP, CHFN, CCRN
Marie Galvao, MSN, ANP-BC, CHFN
Nita Reigle, RN, MSN, ACNP-BC, CHFN
Robin J. Trupp, PHD, ACNP-BC, CHFN, FAHA
Sara Paul, DNP, FNP, CHFN
Karol Harshaw-Ellis, MSN, DNP, GNP, A/ACNP-BC

1:00 pm to 5:00 pm

Heart Failure Certification Review Course

About

This course will provide participants with an extensive review of the care of patients with heart failure (HF). Course content will include: review of the pathophysiology, physical assessment techniques, discussion of diagnostic testing, implementation of pharmacologic and non-pharmacologic treatment strategies, and professional issues in HF nursing. Heart Failure expert clinicians will review the most recently updated HF guidelines and share their knowledge, advice and experience with participants. Case studies, question and answer breaks and review of test taking tips will be used to reinforce information and aid participants in preparing to sit for the Certified Heart Failure Nurse (CHFN) exam.

Objectives

At the end of the program, the participant will be able to:

Understand how to conduct complete patient assessment including how to review patient record, symptoms and history.
Describe how to perform a physical assessment and review lab results.
Determine process for integrating assessment into plan of care.
Describe treatment options available (pharmacologic and non-pharmacologic).
Recommend patient referrals.
Evaluate effectiveness of patient therapies and teaching.
Understand the role certification plays in their practice.

Speakers

Ashley Moore-Gibbs, MSN, AGPCNP-BC, CHFN, Sanger Heart & Vascular
Connie Lewis, MSN, ACNP-BC, NP-C, CCRN, CHFN, Vanderbilt Medical Center

7:00 am to 8:30 am

Industry Supported Breakfast Symposium: Learn More About New Corlanor®: What Nurses Need to Know

Presented by Amgen

Speaker

Nancy Albert, PhD, MSN, BSN, RN, CHFN, Cleveland Clinic

Grand Ballroom D/E (5th Floor)

7:15 am to 7:45 am

Heart Failure Nursing Certification Exam Check In

Armstrong Foyer (8th Floor)

8:00 am to 10:00 am

Heart Failure Certification Exam:

About

Please visit Certification website to register and complete application.

If you have any questions please contact Pam Brown, Certification Manager, at pbrown@ahint.com.

Armstrong Ballroom (8th Floor)

8:45 am to 9:00 am

Opening Remarks

Speaker

Sharon Fabbri, RN, NP, CHFN, Loma Linda University Medical Center

Grand Ballroom (5th Floor)

9:00 am to 9:30 am

Presidential Address: “When the Saints Go Marching In” We Stand United In Heart Failure Care!

Learner Objectives

Discuss common goals of heart failure nurses.
Review the strength of an organization.
Discuss attributes of members and volunteers to promote excellence in heart failure care.

Speaker

Connie Lewis, MSN, ACNP-BC, NP-C, CCRN, CHFN, Vanderbilt Medical Center

Grand Ballroom (5th Floor)

9:30 am to 10:30 am

Keynote Address: A Patient's Guide to Living Confidently With Chronic Heart Failure

Learner Objectives

To identify the latest strategies in guiding patients with the goal of coping with the management of chronic heart failure.
To discuss a plan to influence behavior change in heart failure patients.
To be familiar with motivational interviewing skills.

Speaker

Samuel F. Sears, PhD, East Carolina University

Grand Ballroom (5th Floor)

10:45 am to 11:15 am

Product Theater: Furosemide 2.0: A Convenient, Comfortable Alternative Grand Ballroom D/E (5th Floor) to Intravenous Furosemide

Presented by SC Pharmaceuticals

About

Approximately $10b is spent annually in the US alone on clinical diuresis – inducing diuresis with iv furosemide in an emergency room, observation unit and hospital. A novel formulation of furosemide is under development for subcutaneous administration for administration by a wearable patch pump. This would provide convenient iv-like diuresis where and when needed.

Speaker

Pieter Muntendam, MD, President, SC Pharmaceuticals

Grand Ballroom D/E (5th Floor)

10:45 am to 1:15 pm

Exhibit Hall Opening

Napoleon Ballroom (3rd Floor)

11:30 am to 12:00 pm

Product Theater: AdaptivCRT: A New Standard in CRT

Presented by Medtronic

About

AdaptivCRT is a dynamic, physiologic pacing algorithm which enhances cardiac resynchronization therapy (CRT) by adjusting CRT parameters automatically with changes in patient activity levels and conduction status. Dr. Scherschel will discuss CRT patient selection criteria, operation of the algorithm and review the latest clinical evidence available.

Dr. Scherschel specializes in heart rhythm management including complex catheter ablation, intra-cardiac echo, and device management including pacemakers, defibrillators, and cardiac resynchronization therapy at Prairie Heart Institute, St. John’s Hospital in Springfield, Illinois. Presented by Medtronic

Speaker

John Scherschel, MD, Prairie Heart Institute, St. John’s Hospital in Springfield, Illinois

Grand Ballroom D/E (5th Floor)

12:30 pm to 1:00 pm

Product Theater: Offer HOPE to your Advanced Heart Failure patients - the HeartMate II® Left Ventricular Assist Device (LVAD)

Presented by Thoratec

About

Learn about the benefits of LVAD therapy for advanced heart failure. Get an update on ROADMAP study results which supports use of HeartMate II in functionally limited <non-inotrope dependent heart failure patients. Learn when and what patients refer< to for HeartMate II LVAD and find out how to talk to patients about HeartMate II LVAD.
Presented by Thoratec

Speaker

Aditya Bansal, MD, Ochsner Medical Center

Grand Ballroom D/E (5th Floor)

1:00 pm to 3:00 pm

Oral Abstracts Presentations & Awards

About

Results of an Intervention to Improve Memory Performance in Heart Failure Patients: The Testing Effect Phenomenon
Jennifer Viveiros
College of Nursing, University of Massachusetts Dartmouth, North Dartmouth, MA

Feasibility and Acceptability of Health Literacy Measures in Community Dwelling Adults Hospitalized with Heart Failure
Margaret S . Mock
College of Nursing, University Of Massachusetts, Rehoboth, MA

Effects of A Mindfulness-Based Stress Reduction Program on Cardiac Outpatients and Caregivers
Laura James
Preventive Cardiology, Wellspan Health, Gettysburg, PA

Avoidability of Readmission within 7 Days after Hospitalization for Heart Failure
Cathy Eastwood
Nursing, University of Calgary, Calgary, AB, Canada

Speaker

Peggy Kalowes, PhD, RN, CNS, FAHA, Long Beach Memorial and Miller Childrens Hospital

Oak Alley (4th Floor)

1:15 pm to 2:15 pm

Management of HF in CHD Patients

Learner Objectives

Cite common congenital heart disease conditions that are seen in adult patients with heart failure.
Recognize and state how the routine treatment of heart failure may be different in this patient population.
Discuss the challenges and controversies in managing the adult congenital heart failure patient.

Speakers

Ann Laramee, MS ANP-BC ANC-BC CHFN, University of Vermont Medical Center
Sangeeta Shah, MD, Oschner Medical Center

Level: Global

Grand Couteau (5th Floor)

Percutaneous Circulatory Support Temporary, Short Term Devices

Learner Objectives

Define cardiogenic shock and the indications for mechanical circulatory support.
Compare/contrast commonly used percutaneous mechanical support devices.
Identify MCS "best practices" to improve outcomes.

Speakers

Beth Towery Davidson, DNP, ACNP, CHFN, CCRN, TriStar Centennial Medical Center
Carole Ballew, BSN, MSN, ACNP-BC, CCTC, CHFN, University of Virginia Hospital

Level: Beginner

Grand Couteau (5th Floor)

Peripartum Cardiomyopathy: Lessons Learned

Learner Objectives

Learn results of the PPCM PCN trial results.
Learn what the latest guidelines say about managing PPCM.
Review difficult cases that will help with understanding multidisciplinary management of PPCM.
Review the Pathophysiology of PPCM.
Describe the incidence of PPCM in Haiti and the US.
Review treatment guidelines for PPCM including restrictions in lactating women who are breast feeding.

Speakers

Denise Buonocore, MSN, CCRN, ACNPC, CHFN, St. Vincents Multispecialty Group
Kismet Rassmusson, DNP, FNP-BC, CHFN, Intermountain Medical Center
Uri Elkyam, MD, University of California, Los Angeles
Elizabeth Bolton-Harris, ACNP, BC, CHFN

Level: Advanced

Grand Ballroom A (5th Floor)

2:15 pm to 3:15 pm

Oklahoma Heart Hospital Experience with Implanted Hemodynamic Monitoring Systems

Learner Objectives

Discuss the scientific basis for use of hemodynamic monitoring in patients with heart failure.
Review and provide understanding of remotely acquired pulmonary artery pressure signals.
Describe the infrastructure development and evolution of implementation of hemodynamic guided heart failure management.

Speaker

Kathy Suggett, BS, RN, CHFN

Level: Intermediate

Grand Chenier (5th Floor)

The Co-Morbidity Conundrum

Learner Objectives

To identify common co-morbid conditions in patients with heart failure.
To cite management issues related to other disease states in heart failure patients.
To identify treatment modalities for the heart failure patient with co-morbidities.

Speaker

Erin K. Donaho, RN, MS, ANP-C

Level: Global

Grand Ballroom A (5th Floor)

When The Treatment of Cancer Causes Heart Failure: What Every HF Nurse Needs to Know

Learner Objectives

Identify chemotherapeutic agents that can cause myocardial damage.
Discuss methods to protect the myocardium from damage during chemotherapy.
Recognize strategies to prevent further damage to the heart after chemotherapy.

Speaker

Kristen Sethares, PhD, RN, CNE

Level: Global

Grand Couteau (5th Floor)

3:15 pm to 4:00 pm

Break in Exhibit Hall

Napoleon Ballroom (3rd Floor)

4:00 pm to 5:00 pm

Great Debate: Tele-Monitoring: Does it Have Value in Preventing Readmission?

Learner Objectives

To cite methods of telemonitoring for heart failure patients.
To teach critical thinking skills to learners by observing pro and con arguments.
Discuss research on the value of telemonitoring for the heart failure patient

Speakers

Linda Wick, MSN, CNP, CHFN, University of Minnesota
Robin J. Trupp, PHD, ACNP-BC, CHFN, FAHA
Erin Donaho, RN, MS, ANP-C

5:15 pm to 7:00 pm

Moderated Poster Session

Napoleon Ballroom (3rd Floor)

5:30 pm to 7:30 pm

Welcome Reception in the Exhibit Hall

Napoleon Ballroom (3rd Floor)

7:15 pm to 9:00 pm

Industry Supported Dinner Symposia: Implantable Hemodynamic Monitoring: Putting It into Practice

Presented by St. Jude Medical

About

CardioMEMS™ HF System is the first FDA-approved heart failure (HF) monitor, that, when used by clinicians to monitor their NYHA Class III HF patients, including the difficult to treat HFpEF patients, has been shown to significantly reduce HF hospitalizations and improve their quality of life. In this dinner program, you will learn the principles of hemodynamic monitoring in HF and how to translate this into the use of pulmonary artery (PA) pressure monitoring in order to better manage your heart failure patients. HF Centers utilizing the CardioMEMS™ HF System will present their workflow and implementation strategies from both an academic and private community practice setting.

In addition, lessons learned will be shared.

Discuss hemodynamics in heart failure and how it applies to pulmonary artery pressure monitoring.
Describe the use of pulmonary artery pressure management in academic and community settings.
Identify and discuss lessons learned in pulmonary artery pressure management.

Speakers

Brent Lampert, DO
Chairperson: Sara Paul, DNP, FNP, CHFN
Laura Yamokoski, MSN, RN, CCRC, CHFN

Grand Ballroom D/E (5th Floor)

7:00 am to 8:30 am

Industry Supported Breakfast Symposium: Heart to Heart: Achieving Best Outcomes When Caring For Your African American Patients

Supported by an educational grant from Arbor Pharmaceuticals LLC.

About

Heart failure affects approximately 6 million Americans and is the most common diagnosis for hospitalization in patients over 65 years. African Americans are disproportionately affected by heart failure, with a higher prevalence at an early age than whites. Moreover, African Americans with heart failure have higher rates of hospital readmissions and even death when compared to their white counterparts. Health disparities in cardiovascular diseases and care persist and involve social determinants of health and many socioeconomic factors. Health care providers must utilize advances in evidence-based therapeutics and multiple strategies for managing patients with this life threatening illness. Clinicians treating African Americans, and others, must identify and eliminate barriers to attaining treatment goals. By implementing a team approach and a continuum of-care concept, the individual patient, the heart failure population, and healthcare economics will benefit.

Learner Objectives

Objectives:

Identify heart failure (HF) epidemiology and pathophysiology in African Americans (AAs)
Describe HF guidelines and evidence-based pharmacotherapy in AAs
Review evidence from major clinical outcome trials specific to AAs
Recognize how team-based care can be effective in reducing health disparities

Speakers

Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH, Tulane Heart and Vascular Institute, New Orleans, LA
Karol Harshaw-Ellis, MSN, DNP, GNP, A/ACNP-BC, Duke University Health System/Heart Center

Grand Ballroom D/E (5th Floor)

8:30 am to 8:45 am

Opening Remarks

Speaker

Sharon Fabbri, RN, NP, CHFN, Loma Linda University Medical Center

Grand Ballroom A/B/C (5th Floor)

8:45 am to 9:15 am

Keynote Address: A Patient's Perspective: Heart Transplant Recipient Story - A Ticket to Ride on My Cardio Coaster

Learner Objectives

To identify a patient’s viewpoint and perspective while living with chronic heart disease.
To discuss the many barriers patients face with heart failure.

Speaker

CJ Spraggins

Grand Ballroom A/B/C (5th Floor)

9:15 am to 10:15 am

Innovations on the Horizon; What's New in the Management of Heart Failure

Learner Objectives

Cite a new class of therapy for the treatment of Heart Failure.
Recognize the role that tachycardia plays in the management of heart failure and possible new therapies for controlling heart rate.
Restate advances being made the for the treatment of hyperkalemia in the Heart Failure population

Speakers

Sharon Fabbri, RN, NP, CHFN, Loma Linda University Medical Center
Uri Elkyam, MD, University of California, Los Angeles

Grand Ballroom A/B/C (5th Floor)

10:15 am to 11:15 am

It is Not All About the LV: Assessing and Treating RV Failure

Learner Objectives

Restate methods of assessing right ventricular function.
Recognizing differences in LV and RV hemodynamics and response to therapy.
Cite therapies for treating RV failure.

Speakers

J. Thomas Heywood, MD, FACC, Scripps Clinic
Monica Worrell, MSN, RN

Level: Global

Grand Ballroom A (5th Floor)

Keeping Their Attention: Tips for Great Presenting

Learner Objectives

Identify strategies for and distractors from an effective presentation.
Identify appropriate amount of content and number of slides based on time allotment.
Recognize how appearance, body language, and diction can affect a presentation.

Speakers

Robin J. Trupp, PHD, ACNP-BC, CHFN, FAHA, University of Illinois
Sara Paul, DNP, FNP, CHFN, Catawba Valley Cardiology
Elizabeth Wirth, MSN, APN/CCNS, CHFN

Level: Beginner

Grand Chenier (5th Floor)

Uncommon Orgins of Heart Failure: Looking for Zebras

Learner Objectives

Describe the etiology of less common causes of heart failure including Hypertrophic, Infiltrative, and Takotsubo cardiomyopathies.
List of clinical manifestations of Hypertrophic, Infiltrative, and Takotsubo cardiomyopathies.
Outline the most recent recommendations on the diagnosis and management of Hypertrophic, Infiltrative, and Takotsubo cardiomyopathies.

Speakers

Ashley Moore-Gibbs, MSN, AGPCNP-BC, CHFN, Sanger Heart & Vascular
Cindy Bither, MSN, ANP, ACNP, CHFN, Medstar Washington Hospital Center
Maureen Hummel, MSN, CRNP, CHFN

Level: Advanced

11:30 am to 12:30 pm

Product Theater: Exploring Risk Reduction in Thrombosis

About

This lecture will discuss treatment options for patients with deep vein thrombosis and pulmonary embolism, and how they can reduce the risk of recurrent thrombotic events. It will also present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation.

This promotional educational activity is brought to you by Janssen Pharmaceuticals, Inc., and is not certified for continuing medical education. The consultants are paid speakers for Janssen Pharmaceuticals, Inc. The speaker is presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen.

In adherence with PhRMA guidelines, spouses or other guests are not permitted to attend company-sponsored programs.

Speaker

Uri Elkayam, MD, University of Southern California, Los Angeles, CA

Grand Ballroom D/E (5th Floor)

11:30 am to 1:30 pm

Exhibit Hall Opening

Napoleon Ballroom (3rd Floor)

1:30 pm to 3:30 pm

Mechanical Cirulatory Support Power Hours

About

Choosing the Right Candidate fpr LVAD - Sapna Desai, MD
Arrhythmia Burden and Management in the LVAD Patient - Rohit Malhotra, MD
Managing Complications in the LVAD Patient - JoAnn Lindenfeld, MD, FACC

Learner Objectives

Review screening tools that predict successful outcomes following LVAD surgery.
Describe barriers/challenges to successful survival in the LVAD population.
List strategies to optimize marginal potential LVAD candidates.
Review research specific to arrhythmias in LVAD patients.
Describe gaps in research pertaining to management of arrhythmias in LVAD patients.
Outline novel approaches in the management of arrhythmias in LVAD patients.
Describe complications specific to LVAD (pump thrombus, GI bleeding, DLES infection.
Describe proposed mechanism for complications.
Review novel and up-to-date approaches to management of complication.

Speakers

JoAnn Lindenfeld, MD, FACC, Vanderbilt Medical Center
Rohit Malhotra, MD, University of Virginia Health System
Sapna Desai, MD, Ochsner Clinic Foundation

Level: Advanced

Grand Ballroom A (5th Floor)

Palliative and Hospice Care Power Hours

About

Integration of Palliative Care and HF Teams - Carolyn Moffa, RN, BSN, MSN, FNP-C, CHFN
Discussing Prognosis with HF Patients - Denise Buonocore, MSN, CCRN, ACNPC, CHFN
Breathe Easy: Partnering with Palliative Care and Hospice - Tasha Freitag, MSN/MPH

Learner Objectives

Compare and contrast available tools for assessing prognosis in heart failure.
Identify common symptoms experienced at the end of life in advanced heart failure.
Discuss the role of palliative care and/or hospice in inotropes and mechanical circulatory support.
Discuss the disease trajectory for patients with heart failure and how the increased symptom burden may impact quality of life.
Understand prognostic tools for severity of illness and performance status.
Utilize communication strategies and tools to improve communication with patients, families, and the team regarding prognosis and treatment options.
Describe the historical role of palliative care medicine with heart failure patients.
Discuss the need and benefit of incorporating palliative care medicine into a heart failure program.
Describe use of prognostic tools to identify patients at increased risk of mortality.

Speakers

Carolyn Moffa, RN, BSN, MSN, FNP-C, CHFN, Christiana Care Health System
Denise Buonocore, MSN, CCRN, ACNPC, CHFN, St. Vincents Multispecialty Group
Tasha Freitag, MSN/MPH, WellSpan

Level: Intermediate

Grand Couteau (5th Floor)

Readmission Strategies: Transition to Home after Hospitalization for HF: Reducing Hospital Readmissions

About

An Update on CMS and the Hospital Readmissions Reduction Program - Karen Joynt, MD, MPH
How to Effectively Measure Readmission Metrics and Assembling a HF Team - Nita Reigle, RN, MSN, ACNP-BC, CHFN
Key Strategies for Establishing Successful Patient Discharge and Planning - Cherri Basso, BSN, RN-BC, CHFN
The Outpatient Setting: Keeping Patients Out of the Hospital - Sabrina White, DNP, APRN, ACNP-BC

Learner Objectives

Review two strategies in an outpatient disease management program to prevent readmission.
Examine two novel approaches implemented in the outpatient setting that effectively reduce unnecessary and preventable readmissions.
Review how to effectively measure your readmission metrics.
Describe current performance improvement strategies and their effect on heart failure patient outcomes.
Identify key members of your heart failure and discuss their roles.
Discuss the outlook for United States healthcare transformation and CMS readmission reduction program.
Review CMS Initiatives for value-based purchasing.
Review optimal plan of care which will prepare heart failure patients for successful hospital discharge and reduce the risk for re-admission.
Identify evidenced-based opportunities to impact patients with CHF during the transitional timeframe.
Describe quality initiatives to effectively and appropriately reduce unnecessary and preventable re-hospitalizations for patients with CHF.

Speakers

Cheri Basso BSN, RN-BC, CHFN, Washington Mary Hospital
Karen Joynt, MD, MPH, Brigham and Women's Hospital
Nita Reigle, RN, MSN, ACNP-BC, CHFN, University of Virginia Hospital
Sabrina White, DNP, APRN, ACNP-BC, East Jefferson General Hospital

Level: Intermediate

Grand Chenier (5th Floor)

3:30 pm to 4:00 pm

Break in Exhibit Hall

Napoleon Ballroom (3rd Floor)

4:00 pm to 5:00 pm

From Telemarketing to Tele-Management to Mobile Health in Heart Failure Management

Learner Objectives

State research results from telemonitoring randomized controlled studies in heart failure.
Discuss how telemonitoring has evolved into telemanagement and nursing expectations in heart failure.
Describe heart failure related mobile health of the future.

Speakers

Julie Gee, MSN, CNP, CHFN, Virginia Medical Center
Nancy Albert, PhD, MSN, BSN, RN, CHFN, Cleveland Clinic

Level: Intermediate

Grand Chenier (5th Floor)

Hemodynamics for the Provider: Making Sense of the Right Heart Pressures

Learner Objectives

Describe what is measured by a Pulmonary Artery Catheter.
List the factors which can be used to interpret data from a Pulmonary Artery Catheter.
Discuss the use of outpatient hemodynamics in heart failure patients.

Speakers

Cindy Bither, MSN, ANP, ACNP, CHFN, Medstar Washington Hospital Center
Linda Baas, RN, PhD, ACNP, CHFN, University of Cincinnati

Level: Global

Grand Ballroom (5th Floor)

How to Successfully Complete a Research Project

Learner Objectives

The participant will be able to list 3 common reasons clinicians fail to successfully complete a research project.
List 5 characteristics of an ideal research questions for busy clinicians.
Describe 2 tools clinicians can use to validate that their research idea is apt to be successfully completed.

Speaker

Carole Ballew, BSN, MSN, ACNP-BC, CCTC, CHFN, University of Virginia Hospital

Level: Beginner

Grand Couteau (5th Floor)

5:30 pm to 7:00 pm

Industry Supported Dinner Symposium: The ABCs and 123s of Sleep

Presented by ResMed

About

Objectives:

Review and define commonly used terms, abbreviations and therapies used in sleep medicine.
Review and define regulations and requirements for reimbursement of sleep tests and initiated therapies.
Present and discuss an inpatient algorithm for the recognition of sleep apnea in patients with heart failure

Speakers

J. Thomas Heywood, MD, FACC, Scripps Clinic
Robin J. Trupp, PHD, ACNP-BC, CHFN, FAHA, University of Illinois

Grand Ballroom D/E (5th Floor)

7:00 am to 8:30 am

Industry Supported Breakfast Symposium: Clinical Challenge: Hyperkalemia in the HF Patient

Supported by an Educational Grant from Zs Pharmaceuticals

About

Hyperkalemia is a common occurrence in patients with congestive heart failure, particularly when renal failure coexists. Patients with congestive heart failure very commonly, particularly in the advanced stages of the disease, have moderate renal insufficiency, either due to specific heart failure-related renal perfusion changes or as the result of renal involvement from the same processes having caused the heart failure, as is the case with diabetes. The correct use of medications will often effectively deter clinically relevant hyperkalemia. Heart Failure Nurses are often responsible for monitoring, educating, and in some cases prescribing these medications. In this session the speaker will: describe the danger of hyperkaleimia in the HF patient and identify precipitating factors; contrast the mechanism of actions of organic polymer resins and new therapies; and identify potassium containing foods and understanding their dietary role.

Learning objectives:

Describe the danger of hyperkalemia in the HF patient and identify precipitating factors.
Contrast the mechanism of actions of organic polymer resins and new therapies for hyperkalemia.
Identify potassium containing foods and the importance of understanding their dietary role.

Speaker

Marilyn Prasun, RN, PhD, CHFN, CCNS, CNL, FAHA, Memorial Medical Center

8:45 am to 9:00 am

Opening Remarks

Speaker

Ann Laramee, MS ANP-BC ANC-BC CHFN, University of Vermont Medical Center

Grand Ballroom A/B/C (5th Floor)

9:00 am to 10:00 am

Keynote: Health Care Policy Impacting the Roles of Nurses. Focusing on Readmission and Public Reporting

Learner Objectives

Discuss the reluctance of public reporting for health care focusing on readmissions.
Recognize the role of the nurse related to public reporting and health care policies.
Cite the benefits and importance of public reporting and health care policies for readmissions.

Speaker

Karen Joynt, MD, MPH

Grand Ballroom A/B/C (5th Floor)

10:00 am to 11:00 am

AAHFN Membership Meeting and Awards Ceremony

Grand Ballroom A/B/C (5th Floor)

11:15 am to 11:45 am

Incoming President's Address

Speaker

Marilyn Prasun, RN, PhD, CHFN, CCNS, CNL, FAHA, Memorial Medical Center

Grand Ballroom A/B/C (5th Floor)

11:45 am to 12:45 pm

Great Debate: Cardiac Biomarkers: Are They Useful in Managing HF?

Learner Objectives

Restate which cardiac biomarkers are commonly monitored by practitioners while managing heart failure.
To teach critical thinking skills to learners by observing pro and con arguments.

Speakers

Alan Maisel, MD, VA Medical Center
Hector Ventura, MD, FACC, FACP, Ochsner Medical Center

Grand Ballroom A/B/C (5th Floor)

1:00 pm to 2:00 pm

Industry Supported Lunch Symposium: Corlanor®: Presenting a New Treatment Option

Presented by Amgen

Speaker

Hector Ventura, MD, FACC, FACP, Ochsner Medical Center

Grand Ballroom D/E (5th Floor)

2:15 pm to 3:15 pm

AAHFN's Position on Patient Education: Integrating Recommendations into Practice

Learner Objectives

Learn the latest AAHFN position on educating HF patients.
Understand important factors to consider while educating HF patients.
Consider using important methods used to engage and activate patients in their care.

Speakers

Kismet Rassmusson, DNP, FNP-BC, CHFN, Intermountain Medical Center
Linda Baas, RN, PhD, ACNP, CHFN, University of Cincinnati
Maureen Flattery, ANP-BC, Virginia Commonwealth University Health System

Level: Intermediate

Grand Chenier (5th Floor)

Inpatient and Outpatient Biomarkers for HF: What do they tell you?

Learner Objectives

Contrast and compare biomarkers used in different settings for HF.
Identify new biomarkers and how to utilize them.
State which biomarkers should be monitored and how to interpret the results to guide therapy.

Speaker

Alan Maisel, MD, VA Medical Center

Level: Advanced

Grand Ballroom (5th Floor)

The Future of Heart Failure in the Era of Value Based Care

Learner Objectives

State the tenants of value based care.
Discuss how value based care will transform care of the future.
Describe the importance of nurses’ roles in the era of value based purchasing.

Speaker

Nancy Albert, PhD, MSN, BSN, RN, CHFN, Cleveland Clinic

Level: Beginner

Grand Ballroom (5th Floor)

3:30 pm to 4:30 pm

Acute Care of Decompensated Heart Failure Patients Who are Hospitalized: The MD Perspective and The Bedside Nurse Perspective

Learner Objectives

Discuss the differences between the roles of the MD and nurse in care for the heart failure patient.
Consider the importance of communication between the MD and nurse in the care of the decompensated heart failure patient.
Review the clinical practice guidelines for care of the decompensated heart failure patient.

Speakers

Hector Ventura, MD, FACC, FACP, Ochsner Health System
Renee DiGiovanni, RN, Ochsner Health System

Level: Beginner

Grand Ballroom (5th Floor)

Managing the Adverse Effects of Common Heart Failure Medications

Learner Objectives

Learner will identify common side effects of GDMT for heart failure.
Learner will identify other diseases states that can be confused for medication side effects.
Learner will identify non-pharmacological treatments for side effects.